Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks Apart
Tomography · 2025
DOI: 10.3390/tomography11080092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2025. Verfasst von Justine Schoch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Federal Armed Forces Hospital Koblenz, Ruebenacher Strasse 170, 56072 Koblenz, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to investigate the consistency of lesion identification by Prostate Imaging Reporting and Data System (PI-RADS) and the related clinical and histological characteristics in a high-volume tertiary care center. Materials and methods: The analysis used real-world data from 111 patients between 2018 and 2022. Each patient underwent two multiparametric magnetic resonance imaging (MRI) scans of the prostate at different institutions with a median interval of 42 days between the scans, followed by an MRI-fused biopsy conducted 7 days after the second MRI.
Results
The PI-RADS classifications assigned to the index lesions in the in-house prostate MRI were as follows: PI-RADS V, 33.3% (n = 37); PI-RADS IV, 49.5% (n = 55); PI-RADS III, 12.6% (n = 14); and PI-RADS II, 4.5% (n = 5). Cancer detection rates for randomized and/or targeted biopsies were 91.9% (n = 34) for PI-RADS V, 65.5% (n = 36) for PI-RADS IV, 21.4% (n = 3) for PI-RADS III, and 20% (n = 1) for PI-RADS II. Overall, malignant histology was observed in 64.9% (n = 72) of the targeted lesions and 57.7% (n = 64) of the randomized biopsies. In the first performed, external MRI, 18% (n = 20) and 10.8% (n = 12) of the patients were classified in the higher and lower PI-RADS categories, respectively. The biopsy plan was adjusted for 57 patients (51.4%); nevertheless, any cancer could have possibly been identified regardless of the adjustments.
Conclusion
The 6-week interval between the MRI scans did not affect the quality of the biopsy results significantly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Federal Armed Forces Hospital Koblenz, Ruebenacher Strasse 170, 56072 Koblenz, Germany.
- Department of Diagnostic and Interventional Radiology, Federal Armed Forces Hospital Koblenz, Ruebenacher Strasse 170, 56072 Koblenz, Germany.
ORCID-Profile: Daniel Dillinger, Tim Nestler
Zitieren
APA
Schoch, J., Düring, V., Wiedmann, M., Overhoff, D., Dillinger, D., Waldeck, S., Schmelz, H. U., & Nestler, T. (2025). Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks Apart. Tomography. https://doi.org/10.3390/tomography11080092
Vancouver
Schoch J, Düring V, Wiedmann M, Overhoff D, Dillinger D, Waldeck S, et al. Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks Apart. Tomography. 2025. doi:10.3390/tomography11080092
BibTeX
@article{Schoch2025,
author = {Schoch, Justine and Düring, Viola and Wiedmann, Michael and Overhoff, Daniel and Dillinger, Daniel and Waldeck, Stephan and Schmelz, Hans-Ulrich and Nestler, Tim},
title = {Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks Apart},
journal = {Tomography},
year = {2025},
doi = {10.3390/tomography11080092}
}
EUVIMED